CGA/GAS - CGA M-21
GUIDELINE FOR DETERMINING PHARMACOVIGILANCE REPORTING REQUIREMENTS IN NORTH AMERICA (FOR THE U.S. & REFERENCE FOR CANADA)
active, Most Current
Buy Now
| Organization: | CGA/GAS |
| Publication Date: | 1 January 2017 |
| Status: | active |
| Page Count: | 14 |
Document History
January 1, 2022
GUIDELINE FOR DETERMINING PHARMACOVIGILANCE REPORTING REQUIREMENTS IN NORTH AMERICA
This publication provides guidance for pharmacovigilance reporting to FDA and Health Canada. This guidance is intended to aid United States and Canadian companies that market common medical gases...
CGA M-21
January 1, 2017
GUIDELINE FOR DETERMINING PHARMACOVIGILANCE REPORTING REQUIREMENTS IN NORTH AMERICA (FOR THE U.S. & REFERENCE FOR CANADA)
A description is not available for this item.